Photoprotection Education to Share With Patients
Primary and secondary melanoma prevention factors are necessary to reduce patients’ melanoma risk.
STI Trends and a Dermatologist's Role With Ted Rosen, MD
The latest CDC data shows an uptick in syphilis, which can lead to a rare form of alopecia or a presentation of psoriasis.
2023 Fall Clinical Recap: Day 3
Catch up on coverage from the third day of the 2023 Fall Clinical Dermatology Conference.
Addressing Healthcare Disparities and Improving Care for People with Skin of Color With Patient Navigators
Although still in its early stages, the program showcases the potential value of tangible interactions between dedicated navigators and patients in enhancing support and continuity of care.
Adding Cabtreo to the Acne Vulgaris Tool Box
Christopher Bunick, MD, PhD, reviews Cabtreo’s recent FDA approval and what the new triple-combination gel means for acne patients.
APG777: A Promising Breakthrough in IL-13 Targeted Therapy
The pharmacokinetic profile of APG777, characterized by an extended half-life, increased exposure, and reduced clearance compared to lebrikizumab, is promising for patients with IL-13-driven diseases.
40-GEP Identifies Patients Who Benefit Most From Adjuvant Radiation Therapy With Improved Metastasis-Free Survival of cSCC
The goal of Arron et al’s study was to determine if the 40-GEP test could identify high-risk cSCC patients who would benefit from ART in controlling metastatic disease progression.
Enhancing Skin Health With Macrocystis Pyrifera Ferment-Containing Creams
The positive outcomes observed in these cases underscore the potential for these products to revolutionize the way dermatology clinicians address visible signs of facial aging.
Overcoming Early Career Conundrums and Burnout With Muneeb Shah, DO
Shah is presenting alongside a panel of leading experts at Fall Clinical 2023.
A Deep Dive Into the Chronic Spontaneous Urticaria Armamentarium
Dawn Merritt, DO, and Mark Lebwohl, MD, took the stage to explain the history of CSU, the prevalence of testing and food avoidance, approved treatments, and monitoring treatment improvement for the condition.
2023 Fall Clinical Recap: Day 2
Catch up on coverage from the second day of the 2023 Fall Clinical Dermatology Conference.
Camp Wonder: Supporting Children With Life-Threatening Skin Diseases
Francesca Tenconi, president and CEO of Children’s Skin Disease Foundation and Camp Wonder, presented at Fall Clinical 2023 about the challenges of chronic skin conditions in children.
2023 Inflammatory Disease Summit Recap
If you weren’t able to attend the 2023 Inflammatory Disease Summit or want to review our latest coverage and interviews, our full recap has you covered.
Breaking Down JAKs and TYKs
Kristine Kucera, PA-C, gave an in-depth overview of the JAK-STAT pathway at the 2023 Inflammatory Disease Summit.
Patient Perspective: Solutions for Relief After Years of Pain and Itch
Lisa Sanglay, FNP, and Lauren Miller, PA-C, interviewed a patient at IDS 2023 who used to have debilitating atopic dermatitis before seeing Sanglay for help and who prescribed upadacitinib.
Utilizing Biologics in the Management of Moderate to Severe Atopic Dermatitis
April Armstrong, MD, MPH, and Peter Lio, MD, explained the science behind how AD impacts quality of life and biologics on the market to enhance treatment plans.
Reviewing IDS 2023 and Psoriasis Clinical Cases With Tristan Hasbargen, PA-C
Hasbargen presented clinical cases alongside James Del Rosso, DO, at IDS 2023.
Shawn Kwatra, MD: Managing Prurigo Nodularis With Biologics
Kwatra reviewed skin lesions in PN and important treatment considerations for patients at Fall Clinical.
2023 Fall Clinical Recap: Day 1
Catch up on coverage from the first day of the 2023 Fall Clinical Dermatology Conference and the Inflammatory Disease Summit.
QUIZ: What Percentage of Phase 1 Medications Become FDA Approved?
Andrea Nguyen, PA-C, reviewed types of clinical trials, phases, expenses, and more at the 2023 Inflammatory Disease Summit.
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Utilizing Biologics in the Management of Moderate to Severe Atopic Dermatitis")
.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Shawn Kwatra, MD: Managing Prurigo Nodularis With Biologics")
